Skip to main content
. 2019 Jul 22;11:106. doi: 10.1186/s13148-019-0704-3

Fig. 1.

Fig. 1

DNA methylation and response to guadecitabine. a Unsupervised hierarchical clustering of 116 r/r AML patients based on 2774 hypervariable sites (standard deviation > 10%) divided the cases into three clusters which were normal-like, CIMP-like, and intermediate methylation. b Kaplan-Meier survival analysis of 116 cases based on the clusters derived in a. There was a trend for longer survival in the “normal-like” cluster, but this trend was not statistically significant (p = 0.21 by log-rank test)